Some patients with large vessel occlusion strokes may still benefit from thrombolysis even after the traditional 4.5-hour window, new analysis of the TIMELESS trial suggested.
Drs. Thabele (Bay) Leslie-Mazwi; Ashutosh P. Jadhav; Justin M. Cappuzzo; Elad I. Levy; Waleed Brinjikji; & Demi Dawkins each ponder what the next breakthrough in acute ischemic stroke therapy should be, with responses ranging from technology & technique.
Posted April 12, 2021 • Atlanta, GA
In a fortuitous case of mistaken chemical identity, a team of Georgia Tech bioengineers has discovered a promising new way to treat dangerous blood clots without the potentially harmful side effects of other clot-busting drugs.
“It was a happy accident,” said David Ku, Regents’ professor in the George W. Woodruff School of Mechanical Engineering. “This is something we’ve been working on for the past four years, and we’re still sort of scratching our heads.”
Ku and his collaborators explain their “happy accident” in the open access journal
Their research is driven by the need for a better thrombolytic agent – a safer, more efficient treatment for breaking down clots in the immediate wake of a catastrophic event. When a clot develops in an artery – arterial thrombosis – it can stop the flow of blood to major organs, often leading to a stroke or heart attack. Depending on how it i
Vetex Medical Receives FDA Clearance for Revene Thrombectomy Catheter yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.